JBI Critical Appraisal Tool
Assess methodological quality using the Joanna Briggs Institute critical appraisal checklists. Supports RCTs, cohort, cross-sectional, and qualitative study designs with scoring summaries and CSV export.
How to Use
Select a study design tab, add your studies, and answer each checklist item using the radio buttons. Each item can be rated as Yes, No, Unclear, or N/A. Items you have not rated yet stay unanswered, and a study is flagged incomplete until every item has a response, so a partly filled checklist is never scored as if it were finished. The summary shows counts and the proportion of "Yes" responses. JBI does not set a numeric score cut-off for inclusion; decide your own threshold a priori and use the appraisal to inform, not automate, that decision.
Checklist source. The checklist items are reproduced from the JBI critical appraisal tools, © JBI, all rights reserved. JBI grants use of these tools for research purposes only, and they are provided here for that use. The official forms are at jbi.global/critical-appraisal-tools; other enquiries go to JBI at jbisynthesis@adelaide.edu.au.
Versions used: randomised controlled trials, Barker et al., JBI Evidence Synthesis 2023;21(3):494-506. Cohort studies, Barker et al., JBI Evidence Synthesis 2025;23(3). Analytical cross-sectional studies, Barker et al., JBI Evidence Synthesis 2026;24(3):401-8. Qualitative research, the current JBI Critical Appraisal Checklist for Qualitative Research (© JBI, 2026). Record the version in your methods.
Load sample data to see how the tool works, or clear all fields to start fresh.
Q1.Was true randomization used for assignment of participants to treatment groups?
Q2.Was allocation to treatment groups concealed?
Q3.Were treatment groups similar at the baseline?
Q4.Were participants blind to treatment assignment?
Q5.Were those delivering treatment blind to treatment assignment?
Q6.Were treatment groups treated identically other than the intervention of interest?
Q7.Were outcomes assessors blind to treatment assignment?
Q8.Were outcomes measured in the same way for treatment groups?
Q9.Were outcomes measured in a reliable way?
Q10.Was follow-up complete, and if not, were differences between groups in terms of their follow-up adequately described and analyzed?
Q11.Were participants analyzed in the groups to which they were randomized?
Q12.Was appropriate statistical analysis used?
Q13.Was the trial design appropriate, and any deviations from the standard RCT design accounted for in the conduct and analysis?
Q1.Was true randomization used for assignment of participants to treatment groups?
Q2.Was allocation to treatment groups concealed?
Q3.Were treatment groups similar at the baseline?
Q4.Were participants blind to treatment assignment?
Q5.Were those delivering treatment blind to treatment assignment?
Q6.Were treatment groups treated identically other than the intervention of interest?
Q7.Were outcomes assessors blind to treatment assignment?
Q8.Were outcomes measured in the same way for treatment groups?
Q9.Were outcomes measured in a reliable way?
Q10.Was follow-up complete, and if not, were differences between groups in terms of their follow-up adequately described and analyzed?
Q11.Were participants analyzed in the groups to which they were randomized?
Q12.Was appropriate statistical analysis used?
Q13.Was the trial design appropriate, and any deviations from the standard RCT design accounted for in the conduct and analysis?
Next step
Want every included study appraised with the JBI checklists for you?
Two trained reviewers run JBI across every included study, resolve disagreements, and deliver a publication-ready appraisal table.
Our promise: Free rework on search, screening, or synthesis if reviewers push back.
Will your review include a meta-analysis? We run the systematic review and the pooled analysis together, in one project.
Quote my review + meta-analysisTimeline
Your quote states a confirmed delivery date before you commit, and work starts only after you approve it.
If reviewers push back
If reviewers question the search, screening, or synthesis, we rework the section free.
Confidentiality
NDA available on request before any project discussion. Your data, study design, and manuscript stay private either way.
How to Use This Tool
Select Study Design
Choose the checklist that matches your study type: RCTs, cohort, cross-sectional, or qualitative studies.
Add Studies
Enter each study name and respond to every checklist item with Yes, No, Unclear, or Not Applicable.
Review Summary
Check the appraisal summary table showing, per study, the counts of Yes, No, Unclear and Not applicable responses and the number of criteria met, then record your own include, exclude, or seek further information decision.
Export Results
Copy results to clipboard or export as a CSV file for inclusion in your systematic review manuscript.
How JBI compares with RoB 2 and Newcastle-Ottawa is covered in our comparison of quality assessment tools.
We complete JBI appraisal across all included studies.
Want a PhD methodologist to handle the whole project?
Get a full JBI critical appraisal across all included studies. Free rework on search, screening, or synthesis if reviewers push back. Pay only after you approve your quote.
Key Takeaways for Critical Appraisal
Match the checklist to the study design
JBI provides separate checklists for different methodologies because quality criteria vary between study types. Using a cohort checklist for an RCT, or vice versa, would miss design-specific quality indicators and lead to inaccurate appraisals.
Multiple study designs in one review
Mixed-methods systematic reviews often include RCTs, cohort studies, and qualitative research. Appraise each study with its appropriate JBI checklist, then synthesize findings while being transparent about quality differences across designs.
Use scoring as a guide, not a rule
While percentage-based scoring provides a quick quality summary, consider which specific items received 'No' or 'Unclear' ratings. A study scoring 80% but failing on randomization may be more problematic than one scoring 70% with minor reporting gaps.
Report appraisal transparently
Include a complete critical appraisal table in your review showing item-level responses for each study. This allows readers to assess whether your quality judgments are appropriate and facilitates replication of your review methodology.
Critical Appraisal Across Study Designs: The JBI Approach
Critical appraisal is the systematic evaluation of research evidence to judge its trustworthiness, relevance, and applicability, and no single instrument can adequately assess every study design. The JBI critical appraisal tool, developed and maintained by the Joanna Briggs Institute (Aromataris & Munn, 2020), addresses this challenge by providing a suite of design-specific checklists that share a common scoring philosophy while tailoring their questions to the methodological features that matter most for each study type. The JBI suite covers randomized controlled trials, cohort studies, analytical cross-sectional studies, prevalence studies, case reports, case series, and, uniquely among major appraisal frameworks, qualitative research. This JBI checklist online currently includes the randomized controlled trial, cohort, analytical cross-sectional, and qualitative checklists. This breadth makes the JBI system indispensable for mixed-methods and comprehensive systematic reviews that synthesize evidence from heterogeneous study designs. The CASP (Critical Appraisal Skills Programme) checklists serve as a complementary appraisal framework that is particularly popular in the United Kingdom and in health services research, offering streamlined question sets for qualitative studies, cohort studies, and RCTs. For reviews that combine quantitative and qualitative evidence, the Mixed Methods Appraisal Tool (MMAT) developed by Hong et al. (2018) provides a single instrument capable of appraising all empirical study designs within one unified framework.
The qualitative study appraisal tool within the JBI framework deserves particular attention because qualitative evidence plays an increasingly important role in evidence synthesis. The JBI Checklist for Qualitative Research contains 10 items addressing the congruity between the stated philosophical perspective, the methodology, the research question, the data collection methods, the data analysis approach, and the interpretation of results. It also evaluates whether the researcher's cultural and theoretical positioning is clearly stated, a reflexivity assessment that is absent from quantitative appraisal tools and is essential for judging the credibility of interpretive research. When synthesizing qualitative findings across studies, the CERQual (Confidence in Evidence from Reviews of Qualitative Research) approach provides a structured method for rating the certainty of qualitative evidence, analogous to the GRADE framework used for quantitative reviews. For quantitative designs, the JBI RCT checklist assesses randomization, allocation concealment, blinding, and completeness of follow-up, while the cohort checklist evaluates group comparability, exposure measurement, and confounding control. Each item is answered as Yes, No, Unclear, or Not Applicable, and the proportion of Yes responses yields a summary quality score.
The JBI Manual for Evidence Synthesis (Aromataris & Munn, 2020) recommends that two independent reviewers complete the critical appraisal for every included study, with disagreements resolved by discussion or referral to a third reviewer. JBI does not define a cutoff score; the checklists end with an overall decision to include, exclude, or seek further information. Some review teams count Yes responses and set their own threshold, but that is their convention rather than JBI practice, and reviewers should look beyond any count and consider which specific items were rated No or Unclear. A study meeting most criteria but failing on allocation concealment may introduce more bias than one with more unmet criteria that are only minor reporting gaps. PRISMA 2020 (Page et al., 2021) requires transparent reporting of all critical appraisal results, and the Cochrane Handbook (Higgins et al., 2023) emphasizes that quality assessment findings should directly inform the interpretation of review results, including decisions about GRADE certainty of evidence ratings. SUMARI (JBI's System for the Unified Management, Assessment and Review of Information) integrates critical appraisal directly into the review management workflow, allowing teams to conduct JBI assessments within the same platform used for screening and extraction.
Selecting the most appropriate appraisal instrument requires matching the tool to the study design and the level of granularity needed. For randomized trials where domain-level bias judgments are required by journal or funder guidelines, the Cochrane RoB 2 assessment tool provides a five-domain evaluation with traffic light visualization. For non-randomized studies of interventions, the ROBINS-I bias assessment framework offers seven domains with signaling questions tailored to observational comparative designs. When a simpler star-based scoring system is preferred for cohort or case-control studies, the Newcastle-Ottawa Scale calculator provides a widely recognized alternative. The JBI checklists complement all of these tools by covering design categories that the others do not address, including qualitative research, prevalence studies, and case series, making them an essential component of any comprehensive systematic review toolkit. Once your appraisal is complete, record all quality scores alongside study characteristics in your data extraction template to keep all evidence in a single, auditable document.
Frequently Asked Questions
What are JBI critical appraisal checklists?
JBI (Joanna Briggs Institute) critical appraisal checklists are standardized tools developed to assess the methodological quality of different study designs. Each checklist contains a series of questions addressing key aspects of study rigor, such as randomization, blinding, confounding, and appropriate statistical analysis. They are widely used in systematic reviews to determine whether a study meets minimum quality thresholds for inclusion.
How do JBI checklists differ from Cochrane RoB 2?
RoB 2 is specifically designed for randomized controlled trials and focuses on risk of bias across five predefined domains. JBI checklists cover a broader range of study designs including qualitative research, cross-sectional studies, cohort studies, prevalence studies, and RCTs. While RoB 2 uses domain-level judgments (low, some concerns, high), JBI checklists use item-level responses (Yes, No, Unclear, N/A) and end with an overall appraisal decision (include, exclude, or seek further information) rather than a numeric score.
How do I choose the right JBI checklist?
Select the checklist that matches your study design. Use the RCT checklist for randomized trials, the cohort checklist for longitudinal observational studies comparing exposed and unexposed groups, the cross-sectional checklist for prevalence or survey-based studies, and the qualitative checklist for studies using interviews, focus groups, or ethnographic methods. If your review includes multiple study designs, appraise each study with the appropriate checklist.
How should I interpret the JBI scoring?
No. The JBI checklists do not define a cut-off score; each form ends with an overall appraisal decision of include, exclude, or seek further information, made by the review team. Some published reviews count the 'Yes' responses out of the applicable items and set their own threshold, but that is a review-team convention, not JBI guidance. If you use one, set it a priori in your protocol, and always consider which specific items were rated 'No' or 'Unclear' and how they matter for your review question. This tool reports the count of criteria met descriptively and leaves the decision to you.
How do I cite JBI checklists in my manuscript?
Cite the specific checklist you used, as printed on the current JBI form. For randomised controlled trials: Barker TH, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evidence Synthesis. 2023;21(3):494-506. For cohort studies: Barker TH, et al. JBI Evidence Synthesis. 2025;23(3). For analytical cross-sectional studies: Barker TH, et al. JBI Evidence Synthesis. 2026;24(3):401-8. For qualitative research, cite the JBI Manual for Evidence Synthesis chapter named on the checklist. State the checklist and its version in your methods, and report each study's item-level responses in a summary table.
What is the difference between JBI and Cochrane critical appraisal tools?
JBI provides design-specific checklists for 13+ study types (RCTs, cohort, cross-sectional, qualitative, prevalence, case reports, etc.), while Cochrane’s RoB 2 focuses specifically on randomized trials. JBI checklists use a simpler Yes/No/Unclear/Not Applicable format, making them quicker to complete. JBI tools are particularly useful for mixed-design systematic reviews and scoping reviews.
How do I score a JBI critical appraisal checklist?
Each JBI item is rated Yes, No, Unclear, or Not Applicable. There is no standard numeric score. Many reviews report the number of “Yes” responses relative to the total applicable items (e.g., 7/10), and some review teams set their own minimum threshold for inclusion; neither is part of the JBI forms, which end with an overall include, exclude, or seek further information decision. Use the appraisal to inform synthesis decisions and pre-specify any rule in your protocol.
Can I use JBI checklists for scoping reviews?
Yes. Although critical appraisal is optional in scoping reviews (PRISMA-ScR item 12), the JBI Manual for Evidence Synthesis recommends including it when feasible. JBI’s design-specific checklists allow scoping reviews to appraise diverse study types (qualitative, quantitative, and mixed methods) within a single review framework.
Related Research Tools
For randomized controlled trials, complement your JBI appraisal with a domain-level assessment using our Cochrane RoB 2 assessment tool, which generates publication-ready traffic light plots. For observational cohort and case-control studies, score methodological quality with the Newcastle-Ottawa Scale calculator. If you are conducting a scoping review, ensure reporting completeness with our PRISMA-ScR reporting checklist.
Reviewed by
Research Gold Team
Research Gold Team is our group of PhD methodologists and statisticians who deliver our systematic review, meta-analysis and statistical analysis work. The same team writes and checks the guides and tools on this site.
Want every included study appraised with the JBI checklists for you?
A PhD methodologist runs the whole review: protocol, database search, dual screening, data extraction, risk of bias, synthesis, and a PRISMA 2020 manuscript ready for journal submission.
Our promise: Free rework on search, screening, or synthesis if reviewers push back.
Will your review include a meta-analysis? Quote my systematic review and meta-analysis